Register Login

ORASURE TECHNOLOGIES INC (OSUR)

SymbolOSUR
NameORASURE TECHNOLOGIES INC
SectorHEALTH CARE
RegionNorth America
IndustrySurgical & Medical Instruments & Apparatus
Address220 E FIRST ST, BETHLEHEM, PA 18015
Telephone5036416115
Fax—
Email—
Websitehttps://www.orasure.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001116463
Description

OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

Additional info from NASDAQ:
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

2026-08-12 19:06

New Form SCHEDULE 13G - ORASURE TECHNOLOGIES INC <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001019056-26-000128 <b>Size:</b> 15 KB

Read more
2026-08-07 17:20

New Form S-8 - ORASURE TECHNOLOGIES INC <b>Filed:</b> 2026-08-07 <b>AccNo:</b> 0001116463-26-000056 <b>Size:</b> 250 KB

Read more
2026-08-05 20:05

OraSure Announces Second Quarter 2026 Financial Results

Read more
2026-07-31 14:10

New Form SCHEDULE 13G/A - ORASURE TECHNOLOGIES INC <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001142031-26-000015 <b>Size:</b> 6 KB

Read more
2026-07-22 20:10

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

Read more
2026-07-21 20:30

OraSure Receives Emergency Use Authorization for Second Generation Ebola Test

Read more
2026-06-11 13:02

(99% Neutral) ORASURE TECHNOLOGIES INC (OSUR) Announces Regulatory Update

Read more
2026-06-11 12:00

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections

Read more
2026-06-05 20:03

Director McMahon Robert W. 🟢 acquired 46.1K shares of ORASURE TECHNOLOGIES INC (OSUR) Transaction Date: Jun 03, 2026 | Filing ID: 000520

Read more
2026-06-05 20:01

Director Gagliano Nancy J 🟢 acquired 46.1K shares of ORASURE TECHNOLOGIES INC (OSUR) Transaction Date: Jun 03, 2026 | Filing ID: 000519

Read more